Can a chatbot spot cancer risk? new study aims to find out
NCT ID NCT07130487
First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 26 times
Summary
This study is testing whether a chatbot can help primary care patients learn about their risk for hereditary cancer and connect those at high risk with genetic counseling. About 210 adults aged 18-70 from Rutgers Health will use a digital tool to answer questions about their family history. The goal is to see how many people complete the assessment and how many high-risk patients follow up with genetic services.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY CARE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rutgers, The State University of New Jersey
RECRUITINGNew Brunswick, New Jersey, 08901, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.